FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039474311> ?p ?o ?g. }

• W2039474311 abstract "Background Cystic fibrosis (CF) is an inherited disease that leads to damage to lungs, pancreas and other organs. Most people with CF die prematurely from lung disease, but survival has improved markedly over the decades and it is estimated that children born with CF now will live to an average age of 50 years. CF-related diabetes (CFRD) is due to damage to the pancreas, which, over time, loses its capacity to produce sufficient insulin. CFRD is becoming more common owing to the improved survival of people with CF. Objectives The initial aim was to review the methods for screening for CFRD, which can be symptomless but still be causing harm. As the aim of screening and early detection is to allow earlier treatment, a second aim was to assess the effectiveness of treatments. However, during the review it became clear that there were problems with how CFRD is defined, uncertainty about when hyperglycaemia should be treated. Data sources Details of relevant studies were obtained from the usual bibliometric databases – MEDLINE (1950–2008), EMBASE (1980–2008), The Cochrane Library (all sections), Web of Science (1970–2008). Websites of relevant bodies were searched for guidelines and reports. Conference abstracts were searched. Expert co-authors identified key papers. Review methods Systematic reviews of treatments and screening tests. Screening studies were data extracted if they provided sufficient data to construct 2 × 2 tables. Other screening studies were described in narrative manner. The background to CF and CFRD were described in a narrative manner, as was Chapter 2 on problems with defining CFRD. A model was constructed for cost-effectiveness analysis, but was not used because of lack of data. Results Diabetes is usually defined based on the level of blood glucose (BG) at which the risk of retinopathy occurs. For CFRD, it would be better to define it on the level at which the risk of lung disease (pulmonopathy) rises. There seems little place for treatments other than insulin, but the best insulin regimen remains to be confirmed. The best screening test may be by continuous glucose monitoring systems but further evidence is required. Screening may need to detect BG levels of > 8 mmol/l because that may be the level above which pulmonopathy starts in people with CF. Limitations The evidence base for treatment is disappointing with few large randomised controlled trials. The key question is when treatment should start, perhaps at the post-prandial hyperglycaemia stage. Research is needed. Until that is done, we cannot be sure what we are screening for, and, therefore, which screening strategy should be used. Conclusions The definition of CFRD should probably be based on pulmonopathy risk, rather than using the classical definition of diabetes. That implies that we should be screening for a wider range of hyperglycaemia than in other forms of diabetes, perhaps to detect BG excursions of > 8 mmol/l. Insulin treatment may need to start at lower levels than formerly accepted. Funding The National Institute for Health Research Health Technology Assessment programme." @default.
• W2039474311 created "2016-06-24" @default.
• W2039474311 creator A5043554952 @default.
• W2039474311 creator A5046828043 @default.
• W2039474311 creator A5049445455 @default.
• W2039474311 creator A5058932170 @default.
• W2039474311 creator A5064429549 @default.
• W2039474311 creator A5064980874 @default.
• W2039474311 creator A5068047642 @default.
• W2039474311 creator A5068981280 @default.
• W2039474311 creator A5089289582 @default.
• W2039474311 date "2012-05-01" @default.
• W2039474311 modified "2023-10-14" @default.
• W2039474311 title "Screening for cystic fibrosis-related diabetes: a systematic review." @default.
• W2039474311 cites W124578765 @default.
• W2039474311 cites W1550058727 @default.
• W2039474311 cites W160106916 @default.
• W2039474311 cites W1605307665 @default.
• W2039474311 cites W1626102637 @default.
• W2039474311 cites W1866006235 @default.
• W2039474311 cites W1910424113 @default.
• W2039474311 cites W1963953120 @default.
• W2039474311 cites W1967748644 @default.
• W2039474311 cites W1969427484 @default.
• W2039474311 cites W1969881162 @default.
• W2039474311 cites W1970431627 @default.
• W2039474311 cites W1972306903 @default.
• W2039474311 cites W1972309249 @default.
• W2039474311 cites W1973441812 @default.
• W2039474311 cites W1974173049 @default.
• W2039474311 cites W1974930838 @default.
• W2039474311 cites W1976264709 @default.
• W2039474311 cites W1976968491 @default.
• W2039474311 cites W1981362726 @default.
• W2039474311 cites W1981440346 @default.
• W2039474311 cites W1983818979 @default.
• W2039474311 cites W1984005894 @default.
• W2039474311 cites W1984237940 @default.
• W2039474311 cites W1984880642 @default.
• W2039474311 cites W1985108007 @default.
• W2039474311 cites W1985619693 @default.
• W2039474311 cites W1987479562 @default.
• W2039474311 cites W1989028703 @default.
• W2039474311 cites W1990660543 @default.
• W2039474311 cites W1993199144 @default.
• W2039474311 cites W1995662380 @default.
• W2039474311 cites W1996433538 @default.
• W2039474311 cites W1998153432 @default.
• W2039474311 cites W1998496055 @default.
• W2039474311 cites W2004070322 @default.
• W2039474311 cites W2004084637 @default.
• W2039474311 cites W2004100157 @default.
• W2039474311 cites W2006854235 @default.
• W2039474311 cites W2008645871 @default.
• W2039474311 cites W2009132037 @default.
• W2039474311 cites W2009517399 @default.
• W2039474311 cites W2011271212 @default.
• W2039474311 cites W2011394954 @default.
• W2039474311 cites W2013051176 @default.
• W2039474311 cites W2014127296 @default.
• W2039474311 cites W2014597489 @default.
• W2039474311 cites W2014679781 @default.
• W2039474311 cites W2015044617 @default.
• W2039474311 cites W2015478670 @default.
• W2039474311 cites W2016713016 @default.
• W2039474311 cites W2016841971 @default.
• W2039474311 cites W2019206765 @default.
• W2039474311 cites W2022954151 @default.
• W2039474311 cites W2023802021 @default.
• W2039474311 cites W2024403135 @default.
• W2039474311 cites W2024517315 @default.
• W2039474311 cites W2028214395 @default.
• W2039474311 cites W2029523760 @default.
• W2039474311 cites W2030415363 @default.
• W2039474311 cites W2030551462 @default.
• W2039474311 cites W2031245034 @default.
• W2039474311 cites W2032611128 @default.
• W2039474311 cites W2033486064 @default.
• W2039474311 cites W2034996827 @default.
• W2039474311 cites W2035576214 @default.
• W2039474311 cites W2036434602 @default.
• W2039474311 cites W2037595067 @default.
• W2039474311 cites W2037712857 @default.
• W2039474311 cites W2038008764 @default.
• W2039474311 cites W2038481441 @default.
• W2039474311 cites W2039735560 @default.
• W2039474311 cites W2042221089 @default.
• W2039474311 cites W2043557474 @default.
• W2039474311 cites W2046556853 @default.
• W2039474311 cites W2047677420 @default.
• W2039474311 cites W2047967978 @default.
• W2039474311 cites W2048645842 @default.
• W2039474311 cites W2049050537 @default.
• W2039474311 cites W2053220154 @default.
• W2039474311 cites W2053288700 @default.
• W2039474311 cites W2053714512 @default.
• W2039474311 cites W2061309104 @default.
• W2039474311 cites W2061822958 @default.
• W2039474311 cites W2062775123 @default.
• W2039474311 cites W2063255073 @default.

• next